Radioiodine‐131‐Labeled Theranostic Nanoparticles for Transarterial Radioembolization and Chemoembolization Combination Therapy of VX2 Liver Tumor
Advanced Healthcare Materials · 2023-12 · 12 (32)
DOI: 10.1002/adhm.202301559 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 27.10.2023. Verfasst von Guorong Jia und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, The First Affiliated Hospital of Naval Medical University, Shanghai, 200433, China. Hauptthemen laut MEDLINE: Liver Neoplasms, Carcinoma, Hepatocellular, Chemoembolization, Therapeutic, Nanoparticles. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Shanghai Pujiang Program.
Abstract (Originalsprache)
In interventional treatment, materials are administered into the blood supply artery and directly delivered to tumors, offering proper scenarios for nanomedicine potential clinical applications. Transarterial chemoembolization (TACE) and transarterial radioembolization (TARE) are effective treatment methods for hepatocellular carcinoma (HCC), but postoperative residual tumor may result in intrahepatic recurrence and distant metastasis. The combination therapy of TACE and TARE based on multifunctional nanoparticles (NPs) is expected to overcome the drug resistance in hypoxic tumors and improve the therapeutic effect. Herein, BaGdF 5 NPs are synthesized and then coated with polydopamine (PDA), conjugated with the chemotherapeutic drug cis‐diamminedichloride platinum (CDDP), radio‐labeled with therapeutic radionuclide 131 I, yielding 131 I‐BaGdF 5 @PDA‐CDDP NPs. The in vitro anti‐cancer effects of 131 I‐BaGdF 5 @PDA‐CDDP NPs are confirmed using CCK‐8 and γ‐H2AX assays in Huh7 cells. Mixed with Lipiodol, 131 I‐BaGdF 5 @PDA‐CDDP NPs are injected into the hepatic artery via a microcatheter to realize the TACE and TARE combination therapy in a rabbit VX2 liver tumor model. The results indicate that glucose metabolism is clearly decreased based on 18 F‐FDG PET imaging and the apoptosis of tumor cells is increased. Furthermore, 131 I and BaGdF 5 NPs can be used for SPECT imaging and CT/MR imaging respectively, facilitating real‐time monitoring of the in vivo biodistribution of 131 I‐BaGdF 5 @PDA‐CDDP NPs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nuclear Medicine, The First Affiliated Hospital of Naval Medical University, Shanghai, 200433, China.
- Department of Radiology, The First Affiliated Hospital of Naval Medical University, Shanghai, 200433, China.
- Department of Interventional Radiology, The First Affiliated Hospital of Naval Medical University, Shanghai, 200433, China.
ORCID-Profile: Guorong Jia, Changjing Zuo
Förderung
- National Natural Science Foundation of China
- Shanghai Pujiang Program
Zitieren
APA
Jia, G., Wang, T., Li, R., Li, X., Sun, G., Chen, W., Peng, Y., Cheng, C., Yang, J., & Zuo, C. (2023). Radioiodine‐131‐Labeled Theranostic Nanoparticles for Transarterial Radioembolization and Chemoembolization Combination Therapy of VX2 Liver Tumor. Advanced Healthcare Materials, 12(32). https://doi.org/10.1002/adhm.202301559
Vancouver
Jia G, Wang T, Li R, Li X, Sun G, Chen W, et al. Radioiodine‐131‐Labeled Theranostic Nanoparticles for Transarterial Radioembolization and Chemoembolization Combination Therapy of VX2 Liver Tumor. Advanced Healthcare Materials. 2023;12(32). doi:10.1002/adhm.202301559
BibTeX
@article{Jia2023,
author = {Jia, Guorong and Wang, Tao and Li, Rou and Li, Xiao and Sun, Gaofeng and Chen, Wei and Peng, Ye and Cheng, Chao and Yang, Jijin and Zuo, Changjing},
title = {Radioiodine‐131‐Labeled Theranostic Nanoparticles for Transarterial Radioembolization and Chemoembolization Combination Therapy of VX2 Liver Tumor},
journal = {Advanced Healthcare Materials},
year = {2023},
volume = {12},
number = {32},
doi = {10.1002/adhm.202301559}
}
EUVIMED